05.04.2019
- Frankfurt / Weinheim, 03 April 2019. Seven companies from the chemical and pharmaceutical industries have been awarded the "Best Employer in Chemistry" prize as part of the new...
14.02.2019
- US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for...
26.11.2018
- US biopharma AbbVie has signed a deal with UK drug discovery and development group Mission Therapeutics to develop specific deubiquitylating enzymes (DUBs) for treating Alzheimer’s...
10.04.2018
- Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...
21.11.2017
- Boehringer Ingelheim has been granted its first biosimilar approval in Europe, receiving authorization to market Cyltezo for treating a variety of chronic inflammatory diseases in...
16.06.2017
- A federal jury in its home state of Illinois has ordered US drugmaker AbbVie to pay $15 million to cover current medical expenses and future care for a 10-year-old boy in...
26.04.2017
- The chemical industry is the most important supplier of the pharmaceutical industry, but it can´t keep pace with the economic strength and R&D intensity of pharma. This underlines...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...